Albertsons Companies, Inc. (ACI) — closed signal from December 10, 2025
Partial Published before the outcome was known, scored automatically when the window closed on March 10, 2026.
Predicted vs. what happened
What happened
Reached 43% of the predicted growth at its peak, without hitting the target.
The thesis — published December 10, 2025
Albertsons looks like a short-term trade rather than a long-term safe pick. Investors are very excited about its private-label products and recent product programs, but the company still has balance-sheet and merger questions. A bounce in the next 0-3 months is possible because many people are buying, yet the deal uncertainty keeps conviction low.
Primary drivers
- Big U.S. grocery and pharmacy chain with growing private-label brands.
- New nationwide product rollout and Innovation Launchpad show product effort.
- Strong investor enthusiasm and high trading volume point to active buying.
- Merger and regulatory questions make gains possible but risky.
How it played out
ACI: target missed after a partial rise
Lyra published ACI at $17.49 on 2025-12-10 as a short-term trade with 18% expected growth. The thesis pointed to private-label brands, a nationwide product rollout, Innovation Launchpad, active buying, and high trading volume. It also said balance-sheet, merger, and regulatory questions kept conviction low.
Inside the window, ACI rose but did not reach the $20.64 target. The peak was $18.83 on 2026-02-17, with a 7.7% gain. It never got there. By 2026-03-10, the stock ended at $17.23. The thesis partially played out, but the target was missed.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.